Phase I study on the sequential administration of recombinant human interferon-gamma and recombinant human interleukin-2 in patients with metastatic solid tumors.
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
J W
JW
Baars
J
J
Wagstaff
E
E
Boven
J B
JB
Vermorken
C J
CJ
van Groeningen
R J
RJ
Scheper
J C
JC
Fonk
H W
HW
Nijman
C R
CR
Franks
O
O
Damsma
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage / Q000009:adverse effects; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage
D007376:Interleukin-2; D011994:Recombinant Proteins; D007371:Interferon-gamma